Li, Z., & Han, X. (2020). Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020. International journal of hyperthermia, 37(1), 1312. https://doi.org/10.1080/02656736.2020.1847331
Citácia podle Chicago (17th ed.)Li, Zhaonan, a Xinwei Han. "Re: Chen S, Shi M, Shen L, Et al. Microwave Ablation Versus Sorafenib for Intermediate-stage Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization Refractoriness: A Propensity Score Matching Analysis. Int J Hyperthermia 2020." International Journal of Hyperthermia 37, no. 1 (2020): 1312. https://doi.org/10.1080/02656736.2020.1847331.
Citácia podľa MLA (8th ed.)Li, Zhaonan, a Xinwei Han. "Re: Chen S, Shi M, Shen L, Et al. Microwave Ablation Versus Sorafenib for Intermediate-stage Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization Refractoriness: A Propensity Score Matching Analysis. Int J Hyperthermia 2020." International Journal of Hyperthermia, vol. 37, no. 1, 2020, p. 1312, https://doi.org/10.1080/02656736.2020.1847331.